logo
CoreLife Eatery to pay $7.8 million for falsely claiming relief funds

CoreLife Eatery to pay $7.8 million for falsely claiming relief funds

Yahoo05-05-2025
ALBANY, N.Y. (WIVT/WBGH) – A local healthy restaurant chain is on the hook for over $7.8 million in restitution after admitting to falsely certifying its eligibility for a restaurant relief fund during the pandemic in 2021, the Department of Justice announced Monday.
CoreLife Eatery, LLC, which has locations throughout New York, Pennsylvania and other states, including a Vestal location, will pay $7,809,373 for violating the False Claims Act. In 2021, Congress enacted the Restaurant Revitalization Fund (RRF) to support small businesses during the COVID-19 pandemic.
Qualifying restaurants would be eligible for grants to subsidize their pandemic-related losses and stay in business. 'Under the program, any restaurant that—together with its affiliated businesses—owned or operated more than 20 locations as of March 13, 2020, was ineligible for RRF funding,' the release said.
CoreLife, as part of the settlement for $7.8 million, admitted to owning and operating 29 locations as of the March 13, 2020, deadline.
'The Restaurant Revitalization Fund was created to support certain small businesses facing the economic hardships of the COVID-19 pandemic,' said United States Attorney John A. Sarcone III.
'By submitting false information about its size to obtain a grant, CoreLife not only diverted funds from eligible recipients but also eroded public trust in critical relief efforts. Our office remains committed to enforcing the False Claims Act and holding accountable those who misrepresent their eligibility for federal funding,' Sarcone III added.
The relator in the settlement will receive nearly $1.2 million.
President Trump suggests new trade deals could come this week
Business of the Week: Warehouse Carpet & Flooring Outlets
Police week kicks-off with Binghamton flag raising
President Trump wants to reopen Alcatraz
Operation Babylift 50 years later: Crash survivor keeps history alive
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

CVS unit must pay $290 million in drug whistleblower lawsuit, judge rules
CVS unit must pay $290 million in drug whistleblower lawsuit, judge rules

Yahoo

time7 minutes ago

  • Yahoo

CVS unit must pay $290 million in drug whistleblower lawsuit, judge rules

A federal judge ordered CVS Health's pharmacy benefit manager unit to pay $289.9 million in damages and penalties after it overcharged Medicare for prescription drugs. In a Tuesday decision, Chief Judge Mitchell Goldberg in Philadelphia federal court tripled to $285 million the damages he had ordered CVS Caremark to pay in June, citing the federal False Claims Act. He added a $4.87 million civil fine. Goldberg rejected CVS' request to pay less, saying that while CVS Caremark was liable for only two years of overbilling, evidence at trial "made clear that the fraud was financially motivated, not the result of some innocent or mistaken belief." CVS, based in Woonsocket, said on Wednesday it plans to appeal. Last month, a Manhattan federal judge ordered CVS' Omnicare unit to pay $948.8 million in a separate whistleblower lawsuit alleging fraudulent billing. CVS plans to appeal that judgment. Goldberg presided in March over a non-jury trial in the whistleblower case brought by Sarah Behnke, a former head actuary for Medicare Part D at Aetna. She accused CVS Caremark of having caused health insurers such as Aetna to submit inflated claims since 2010 to the Centers for Medicare and Medicaid Services (CMS), while pharmacies such as Rite Aid and Walgreens WBA.O were paid less. CVS argued that the original $95 million in damages was substantial, and punitive damages should be limited to $95 million. But the judge said CVS Caremark's fraud not only financially harmed the government, but diminished public confidence in it. "CMS relies on companies like Caremark to truthfully and accurately report Part D drug prices," he wrote. "Caremark's conduct broke CMS's trust, and as a result, the public's trust in CMS." Behnke sued in 2014. CVS bought Aetna four years later. The False Claims Act lets whistleblowers sue on behalf of the government and share in recoveries, typically 15% to 30%. This article originally appeared on The Providence Journal: Judge: CVS Caremark overcharged Medicare for prescription drugs Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

US and EU frame the ongoing deal between the trading partners and solidify some commitments
US and EU frame the ongoing deal between the trading partners and solidify some commitments

The Hill

time9 minutes ago

  • The Hill

US and EU frame the ongoing deal between the trading partners and solidify some commitments

WASHINGTON (AP) — The United States and the European Union on Thursday issued a joint statement that frames the ongoing deal between the trading partners and solidifies some trade commitments. 'This Framework Agreement will put our trade and investment relationship — one of the largest in the world — on a solid footing and will reinvigorate our economies' reindustrialization,' the document reads. Together, the U.S. and the EU have 44% of the global economy. Key points in the letter include a 15% U.S. tariff rate on most European goods, with specifics on auto tariffs tied to EU legislative actions. In addition, the EU agrees to eliminate tariffs on industrial goods and many agricultural products, while the U.S. will reduce tariffs accordingly. The agreement also covers $750 billion in energy purchases and $600 billion in EU investments by 2028. The agreement also addresses non-tariff barriers, digital trade and environmental regulations. In July, President Donald Trump and European Commission President Ursula von der Leyen met briefly at Trump's Turnberry golf course in Scotland and announced a sweeping trade deal that imposes 15% tariffs on most European goods, warding off Trump's threat of a 30% rate if no deal had been reached by Aug. 1. Before the Republican U.S. president returned to office for his second term, the U.S. and the EU maintained generally low tariff levels in what is the largest bilateral trading relationship in the world, with about $2 trillion, around 1.7 trillion euros, in annual trade.

U.S., Europe release new details on auto tariffs under trade deal
U.S., Europe release new details on auto tariffs under trade deal

Axios

time9 minutes ago

  • Axios

U.S., Europe release new details on auto tariffs under trade deal

U.S. and European officials released a joint statement on Thursday that outlined details of a trade deal — including reduced tariffs on autos that will take effect once Europe eliminates its own tariffs on U.S. goods. Why it matters: It is the only official text of the agreement since Trump announced the deal in Scotland late last month. Details: The text of the statement largely confirms what Trump announced alongside European Commissioner Ursula von der Leyen, including a 15% across-the-board tariff rate for U.S.-bound goods. The statement says European autos and auto parts — currently subject to a 25% tariff rate — will benefit from the lower rate only when the bloc "formally introduces the necessary legislative proposal to enact the tariff reductions" on U.S. goods. Europe said that it would drop tariff rates on U.S. goods to zero.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store